Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Zoledronate plus calcium and vitamin D may prevent bone loss in patients receiving
adjuvant chemotherapy for breast cancer. It is not yet known which regimen is more effective
in preventing bone loss.
PURPOSE: This randomized phase III trial is comparing two regimens of zoledronate plus
calcium and vitamin D to see how well they work in preventing bone loss in women who are
receiving adjuvant chemotherapy for breast cancer.